Profile
David Thomson is currently a Professor of Pharmaceutical Sciences at North Carolina Central University and a Vice President at Shire Human Genetic Therapies, Inc. He was previously the Chief Operating Officer at Precision BioSciences, Inc. from 2019 to 2021.
Thomson holds a doctorate degree from Yale University and the University of Toronto, and an undergraduate degree from the University of Strathclyde.
David Thomson active positions
| Companies | Position | Start |
|---|---|---|
North Carolina Central University
North Carolina Central University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Corporate Officer/Principal | - |
Former positions of David Thomson
| Companies | Position | End |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Operating Officer | 2021-07-01 |
Training of David Thomson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina Central University
North Carolina Central University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
- Stock Market
- Insiders
- David Thomson
















